Business Context and Reporting Period
Company: BioLife Solutions, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 26, 2026
Reporting Period: Fourth quarter and full year ended December 31, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This 8-K serves as a notification that financial results were announced via a press release (Exhibit 99.1), but the specific metrics are not embedded in the body of this document.
Material Changes
No material changes or comparative financial data are detailed within the text of this filing. The document references a press release for operational highlights and financial results but does not summarize the specific changes versus prior periods.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on February 26, 2026, announcing financial results and operational highlights.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are described in this filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 26, 2026) for actual revenue, earnings, and cash flow figures.
- Verify the specific operational highlights mentioned in the press release.
- Check for any forward-looking guidance or updated outlook provided in the attached press release.
- Confirm if the press release contains any material risk factors or unusual items not listed in this 8-K summary.